Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 81.26% is 245% above its 5-year average of 23.52%, near the high end of its 5-year range (0.00%–93.58%).
3.84% below its 12-month average of 84.51%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 93.58%.
GROSS MARGIN
81.26%
GROSS MARGIN AVG TTM
84.51%
GROSS MARGIN AVG 3Y
38.00%
GROSS MARGIN AVG 5Y
23.52%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.84%
CURRENT VS 3Y AVG
+113.86%
CURRENT VS 5Y AVG
+245.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+96.38%
vs the sector median at left
Alpha Cognition Inc
Market Cap
$139.47M
Gross Margin
81.26%
TTM Avg
84.51%
3Y Avg
38.00%
5Y Avg
23.52%
Market Cap
$139.84M
Gross Margin
97.20%
TTM Avg
90.61%
3Y Avg
91.14%
5Y Avg
61.44%
Market Cap
$139.04M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
12.53%
5Y Avg
23.21%
Market Cap
$137.80M
Gross Margin
61.99%
TTM Avg
62.83%
3Y Avg
59.84%
5Y Avg
59.96%
Market Cap
$136.67M
Gross Margin
97.90%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$136.57M
Gross Margin
3.67%
TTM Avg
16.70%
3Y Avg
18.97%
5Y Avg
8.54%
Market Cap
$143.60M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$143.84M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $139.47M | 81.26% | 84.51% | 38.00% | 23.52% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | 97.20% | 90.61% | 91.14% | 61.44% |
| Immuneering Corporation (IMRX)vs › | $139.04M | 0.00% | 0.00% | 12.53% | 23.21% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 61.99% | 62.83% | 59.84% | 59.96% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | 97.90% | 100.00% | 100.00% | 100.00% |
| Organigram Global Inc. (OGI)vs › | $136.57M | 3.67% | 16.70% | 18.97% | 8.54% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 63.13% | 64.40% | 63.36% | 62.40% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
Gross Margin
81.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 93.58% |
| 2026-03-31 | 92.31% |
| 2025-12-31 | 90.97% |
| 2025-09-30 | 77.89% |
| 2025-06-30 | 67.78% |
| 2025-03-31 | 71.44% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
